SELLAS rises as Q1 update suggests lead program nears final analysis
SELLAS Life Sciences Group, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $9.07
+19% in 7d after detection
Post-detection moves
1h
—
1d
+14%
3d
+12%
7d
+19%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS